A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma (Q56898845)
article
Language:
Current Data About A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
(P31) (Q13442814)

(P304) 489-98

(P407) (Q1860)

(P433) 3

(P478) 29

(P577) +2011-06-00T00:00:00Z

(P921) (Q181600)

(Q63088173)
(P248)
(P683) 4305

(Q974135)
(P887)

(Q416975)
(P887)

(P1433) (Q2312231)

(P1476) "A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma" (language: en)

(P2093) Evan M Hersh
(P1545) 1

Steven J O'Day
(P1545) 2

John Powderly
(P1545) 3

Khuda D Khan
(P1545) 4

Anna C Pavlick
(P1545) 5

Lee D Cranmer
(P1545) 6

Wolfram E Samlowski
(P1545) 7

Geoffrey M Nichol
(P1545) 8

Michael J Yellin
(P1545) 9

Jeffrey S Weber
(P1545) 10

(P2860) (Q35680356)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q38502534)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q33372613)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q37483961)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q36846876)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q56888810)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q36717901)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q37008621)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q37288227)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q34959906)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q36909389)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q46087025)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q24679736)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q34657638)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q34657668)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q27860904)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q37248662)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q46106546)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q28265610)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q37387037)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q36900721)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q43293811)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10637-009-9376-8
(P813) Sunday, January 21, 2018

(Q34614776)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/20082117
(P813) Saturday, December 12, 2020
(P887)

(Q34563596)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/20082117
(P813) Saturday, December 12, 2020
(P887)

(Q81703535)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/20082117
(P813) Saturday, December 12, 2020
(P887)

other details
description article

External Links
(P356) 10.1007/S10637-009-9376-8
(P698) 20082117